10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The immunocompromised host represents a vulnerable population with impaired immune defenses, predisposing them to heightened susceptibility to infections and infectious complications. Individuals with compromised immune systems may include those with primary immunodeficiency disorders, secondary immunodeficiencies due to underlying medical conditions or treatments, and recipients of immunosuppressive therapies following organ or bone marrow transplantation. In the immunocompromised host, the body's ability to mount an effective immune response against pathogens is compromised, leading to increased susceptibility to opportunistic infections and a higher risk of morbidity and mortality. Consequently, managing infections in immunocompromised individuals presents unique challenges for healthcare providers, necessitating a multidisciplinary approach that integrates rigorous infection prevention strategies, vigilant surveillance for infectious complications, and tailored therapeutic interventions to optimize patient outcomes and minimize the risk of infectious complications.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria